Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06357533 |
|---|---|
| Brief Title: | Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10) |
| First Submitted : | April 5, 2024 |
| First Submitted that Met QC Criteria : | April 5, 2024 |
| First Posted : | April 10, 2024 |
| Last Update Submitted that Met QC Criteria : | May 14, 2024 |
| Last Update Posted : | May 16, 2024 |